2547 related articles for article (PubMed ID: 32492165)
1. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
2. The Metabolic Changes and Immune Profiles in Patients With COVID-19.
He B; Wang J; Wang Y; Zhao J; Huang J; Tian Y; Yang C; Zhang H; Zhang M; Gu L; Zhou X; Zhou J
Front Immunol; 2020; 11():2075. PubMed ID: 32983157
[TBL] [Abstract][Full Text] [Related]
3. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
5. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological features of severe and moderate coronavirus disease 2019.
Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
10. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
Shi S; Qin M; Shen B; Cai Y; Liu T; Yang F; Gong W; Liu X; Liang J; Zhao Q; Huang H; Yang B; Huang C
JAMA Cardiol; 2020 Jul; 5(7):802-810. PubMed ID: 32211816
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.
Zheng Y; Xu H; Yang M; Zeng Y; Chen H; Liu R; Li Q; Zhang N; Wang D
J Clin Virol; 2020 Jun; 127():104366. PubMed ID: 32302954
[TBL] [Abstract][Full Text] [Related]
13. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.
Henry BM; Benoit SW; de Oliveira MHS; Hsieh WC; Benoit J; Ballout RA; Plebani M; Lippi G
Clin Biochem; 2020 Jul; 81():1-8. PubMed ID: 32473151
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
[TBL] [Abstract][Full Text] [Related]
15. Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China.
Lian JS; Cai H; Hao SR; Jin X; Zhang XL; Zheng L; Jia HY; Hu JH; Zhang SY; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Sheng JF; Yang YD
J Zhejiang Univ Sci B; 2020 May; 21(5):369-377. PubMed ID: 32425002
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Wang D; Hu B; Hu C; Zhu F; Liu X; Zhang J; Wang B; Xiang H; Cheng Z; Xiong Y; Zhao Y; Li Y; Wang X; Peng Z
JAMA; 2020 Mar; 323(11):1061-1069. PubMed ID: 32031570
[TBL] [Abstract][Full Text] [Related]
17. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
18. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
[No Abstract] [Full Text] [Related]
20. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]